<VariationArchive VariationID="2588" VariationName="NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs)" VariationType="Deletion" Accession="VCV000002588" Version="20" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-06-17" DateCreated="2015-08-07" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17627" VariationID="2588">
      <GeneList>
        <Gene Symbol="NHLRC1" FullName="NHL repeat containing E3 ubiquitin protein ligase 1" GeneID="378884" HGNC_ID="HGNC:21576" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="18120440" stop="18122677" display_start="18120440" display_stop="18122677" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="18120717" stop="18122850" display_start="18120717" display_stop="18122850" Strand="-" />
          </Location>
          <OMIM>608072</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs)</Name>
      <CanonicalSPDI>NC_000006.12:18122137:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="18122138" stop="18122139" display_start="18122138" display_stop="18122139" variantLength="2" positionVCF="18122137" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="18122369" stop="18122370" display_start="18122369" display_stop="18122370" variantLength="2" positionVCF="18122368" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G158fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.18122369_18122370del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.18122369_18122370del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.18122138_18122139del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.18122138_18122139del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016750.1" sequenceAccession="NG_016750" sequenceVersion="1" change="g.5482_5483del">
            <Expression>NG_016750.1:g.5482_5483del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198586.3" sequenceAccession="NM_198586" sequenceVersion="3" change="c.468_469del" MANESelect="true">
            <Expression>NM_198586.3:c.468_469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_940988.2" sequenceAccession="NP_940988" sequenceVersion="2" change="p.Gly158fs">
            <Expression>NP_940988.2:p.Gly158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA115630" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608072.0003" DB="OMIM" />
        <XRef Type="rs" ID="587776542" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00004" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs) AND Myoclonic epilepsy of Lafora 2" Accession="RCV000002706" Version="12">
        <ClassifiedConditionList TraitSetID="666">
          <ClassifiedCondition DB="MedGen" ID="C1850764">Myoclonic epilepsy of Lafora 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs) AND not provided" Accession="RCV000188221" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-01-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs) AND Lafora disease" Accession="RCV000192029" Version="16">
        <ClassifiedConditionList TraitSetID="792">
          <ClassifiedCondition DB="MedGen" ID="C0751783">Lafora disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-22" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198586.3(NHLRC1):c.468_469del (p.Gly158fs) AND Inborn genetic diseases" Accession="RCV002326660" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-22" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2015-08-07" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12958597</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16134145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16311711</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18263761</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18311786</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20738377</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25683376</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28556688</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301563</ID>
          <ID Source="BookShelf">NBK1389</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="666" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8696" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LAFORA DISEASE 2</ElementValue>
                <XRef Type="MIM" ID="620681" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, progressive myoclonic, 2b</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myoclonic epilepsy of Lafora 2</ElementValue>
                <XRef ID="MONDO:0800306" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MELF2</ElementValue>
                <XRef Type="MIM" ID="620681" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">NHLRC1-Related Lafora Disease</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301563</ID>
                <ID Source="BookShelf">NBK1389</ID>
              </Citation>
              <XRef ID="C1850764" DB="MedGen" />
              <XRef ID="MONDO:0800306" DB="MONDO" />
              <XRef Type="MIM" ID="620681" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="792" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3139" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lafora disease</ElementValue>
                <XRef ID="Lafora+disease/4074" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009697" DB="MONDO" />
                <XRef ID="230425004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy progressive myoclonic  2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lafora body disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic epilepsy of Lafora</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LBD</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPM2</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MELF</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Progressive myoclonus epilepsy, Lafora type (also known as Lafora disease [LD]) is characterized by focal occipital seizures presenting as transient blindness or visual hallucinations and fragmentary, symmetric, or generalized myoclonus beginning in previously healthy individuals at age eight to 19 years (peak 14-16 years). Generalized tonic-clonic seizures, atypical absence seizures, atonic seizures, and focal seizures with impaired awareness may occur. The course of the disease is characterized by increasing frequency and intractability of seizures. Status epilepticus with any of the seizure types is common. Cognitive decline becomes apparent at or soon after the onset of seizures. Dysarthria and ataxia appear early while spasticity appears late. Emotional disturbance and confusion are common in the early stages of the disease and are followed by dementia. Most affected individuals die within ten years of onset, usually from status epilepticus or from complications related to nervous system degeneration.</Attribute>
                <XRef ID="NBK1389" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8214" />
                <XRef ID="8214" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301563</ID>
                <ID Source="BookShelf">NBK1389</ID>
              </Citation>
              <XRef ID="501" DB="Orphanet" />
              <XRef ID="C0751783" DB="MedGen" />
              <XRef ID="MONDO:0009697" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS254780" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1747487" SubmissionDate="2018-10-25" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="NM_198586.2:c.468_469del|OMIM:254780" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000891687" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="1" SubmitterName="Department Of Genetics, Sultan Qaboos University Hospital, Sultan Qaboos University" OrgID="506653" OrganizationCategory="laboratory" OrgAbbreviation="SQUH-Genetics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <GeographicOrigin>Middle East</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NHLRC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198586.2:c.468_469del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254780" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4684823</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="775277" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-24" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="833342" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000461756" DateUpdated="2019-05-24" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20301563</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18311786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18263761</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12958597</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16134145</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20738377</ID>
          </Citation>
          <Comment>The NHLRC1 c.468_469delAG (p.Gly158ArgfsTer17) variant is a frameshift variant that is predicted to result in premature termination of the protein. This variant is reported as the second most common pathogenic variant in the NHLRC1 gene and the most common deletion (Jansen et al. 2007). This variant has been reported in at least four studies and is found in a total of 21 patients with Lafora type progressive myoclonus epilepsy, including 16 in a homozygous state and five in a compound heterozygous state (Chan et al. 2003; Turnbull et al. 2008; Singh et al. 2008; Lesca et al. 2010). Turnbull et al. (2008) demonstrated a founder effect for the variant in the remote tribal villages of Oman. The p.Gly158ArgfsTer17 variant was absent from 280 controls. It is reported at a frequency of 0.00010 in the African population of the Exome Aggregation Consortium but this is based on one allele in a region of good sequencing coverage so the variant is presumed to be rare. Based on the evidence from the literature and the potential impact of frameshift variants, the p.Gly158ArgfsTer17 variant is classified as pathogenic for Lafora type of progressive myoclonus epilepsy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NHLRC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="C" referenceAllele="CCT" start="18122368" stop="18122370" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198586.2:c.468_469delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254780" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="354829" SubmissionDate="2022-06-30" DateLastUpdated="2022-10-01" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_198586.2:c.468_469delAG|OMIM:254780" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000196909" DateUpdated="2022-10-01" DateCreated="2015-10-05" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18263761</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16311711</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198586.2:c.468_469delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751783" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11732005</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>epb42-spherocytosis_4-24-2014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="22864" SubmissionDate="2019-01-09" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608072.0003_MYOCLONIC EPILEPSY OF LAFORA 2" title="NHLRC1, 2-BP DEL, 468AG_MYOCLONIC EPILEPSY OF LAFORA 2" />
        <ClinVarAccession Accession="SCV000022864" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="7" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 families with myoclonic epilepsy of Lafora-2 (MELF2; 620681), Chan et al. (2003) identified a homozygous 2-bp deletion, 468_469AG, in the NHLRC1 gene. Two additional families had the deletion in compound heterozygosity with a 1-bp deletion (608072.0004), and 1 family had the deletion in compound heterozygosity with the P69A mutation (608072.0002).</Attribute>
              <Citation>
                <ID Source="PubMed">12958597</ID>
              </Citation>
              <XRef DB="OMIM" ID="620681" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NHLRC1" />
          </GeneList>
          <Name>NHLRC1, 2-BP DEL, 468AG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 468AG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608072.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYOCLONIC EPILEPSY OF LAFORA 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2708975" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="1038521|MedGen:C0751783" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001374250" DateUpdated="2024-02-28" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12958597</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18263761</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18311786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20738377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28556688</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly158Argfs*17) in the NHLRC1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 238 amino acid(s) of the NHLRC1 protein. This variant is present in population databases (rs587776542, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with Lafora disease (PMID: 12958597, 18263761, 18311786, 20738377, 28556688). ClinVar contains an entry for this variant (Variation ID: 2588). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NHLRC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.18122369_18122370del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751783" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5122349" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a164072|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002634488" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12958597</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18311786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20738377</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25683376</ID>
          </Citation>
          <Comment>The c.468_469delAG variant, located in coding exon 1 of the NHLRC1 gene, results from a deletion of two nucleotides at nucleotide positions 468 to 469, causing a translational frameshift with a predicted alternate stop codon (p.G158Rfs*17). This mutation is one of the most commonly reported NHLRC1 mutations and has been detected in several individuals with biopsy confirmed Lafora disease in both the homozygous and compound heterozygous states (Singh S et al. Hum. Mutat., 2008 Jun;29:E1-12; Chan EM et al. Nat. Genet., 2003 Oct;35:125-7; Kecmanovi M et al. Clin. Genet., 2016 Jan;89:104-8; Lesca G et al. Epilepsia, 2010 Sep;51:1691-8). In addition to the clinical data presented in the lieterature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NHLRC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198586.2:c.468_469delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="446555" SubmissionDate="2015-07-30" DateLastUpdated="2015-08-07" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="44806" />
        <ClinVarAccession Accession="SCV000241828" DateUpdated="2015-08-07" DateCreated="2015-08-07" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>c.468_469delAG: p.Gly158ArgfsX17 (G158RfsX17) in exon 1 of the NHLRC1 gene (NM_198586.2). The normal sequence with the bases that are deleted in braces is: ACTC{AG}GGGGA. The c.468_469delAG mutation in the NHLRC1 gene has been reported previously in association with Lafora disease in individuals who had a second NHLRC1 mutation on the opposite allele (Chan et al., 2003; Singh et al., 2008, Turnbull et al., 2008). The deletion causes a frameshift starting with codon Glycine 158, changes this amino acid to an Arginine residue and creates a premature Stop codon at position 17 of the new reading frame, denoted p.Gly158ArgfsX17. This mutation is predicted to cause loss of normal protein function through protein truncation, as the last 238 amino acids of the NHLRC1 protein are lost and replaced with 16 incorrect amino acids. Therefore, c.468_469delAG is considered a disease-causing mutation. The variant is found in EPILEPSYV2-1 panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NHLRC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.G158RfsX17</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198586.2:c.468_469delAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5122349" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="446555" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="775277" TraitType="Disease" MappingType="XRef" MappingValue="254780" MappingRef="OMIM">
        <MedGen CUI="CN377204" Name="Myoclonic epilepsy of Lafora 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2708975" TraitType="Disease" MappingType="XRef" MappingValue="C0751783" MappingRef="MedGen">
        <MedGen CUI="C0751783" Name="Lafora disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1747487" TraitType="Disease" MappingType="XRef" MappingValue="254780" MappingRef="OMIM">
        <MedGen CUI="CN377204" Name="Myoclonic epilepsy of Lafora 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="22864" TraitType="Disease" MappingType="Name" MappingValue="MYOCLONIC EPILEPSY OF LAFORA 2" MappingRef="Preferred">
        <MedGen CUI="C1850764" Name="Myoclonic epilepsy of Lafora 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="354829" TraitType="Disease" MappingType="XRef" MappingValue="C0751783" MappingRef="MedGen">
        <MedGen CUI="C0751783" Name="Lafora disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

